Octreotide and urinary glycosaminoglycan in Graves' disease.
作者信息
Chang T C, Yao W C, Chang C C
出版信息
BMJ. 1992 May 30;304(6839):1444. doi: 10.1136/bmj.304.6839.1444.
Abstract
摘要
相似文献
1
Octreotide and urinary glycosaminoglycan in Graves' disease.奥曲肽与格雷夫斯病中的尿糖胺聚糖
BMJ. 1992 May 30;304(6839):1444. doi: 10.1136/bmj.304.6839.1444.
2
Graves' dermopathy: does octreotide scintigraphy predict the response to octreotide treatment?
Thyroid. 1996 Oct;6(5):385-9. doi: 10.1089/thy.1996.6.385.
3
The effect of somatostatin versus corticosteroid in the treatment of Graves' ophthalmopathy.生长抑素与皮质类固醇治疗格雷夫斯眼病的效果比较
Thyroid. 1996 Oct;6(5):381-4. doi: 10.1089/thy.1996.6.381.
4
Octreotide and Graves' ophthalmopathy.奥曲肽与格雷夫斯眼病。
BMJ. 1992 Feb 22;304(6825):507. doi: 10.1136/bmj.304.6825.507-a.
5
Octreotide and Graves' ophthalmopathy and pretibial myxoedema.奥曲肽与格雷夫斯眼病和胫前黏液性水肿
BMJ. 1992 Jan 18;304(6820):158. doi: 10.1136/bmj.304.6820.158.
6
The role of somatostatin analogs in the management of Graves' ophthalmopathy.生长抑素类似物在格雷夫斯眼病管理中的作用。
J Endocrinol Invest. 2003;26(8 Suppl):109-13.
7
Somatostatin analogs for Graves' ophthalmopathy: do they bounce off like a rubber bullet?用于格雷夫斯眼病的生长抑素类似物：它们会像橡皮子弹一样反弹吗？
J Clin Endocrinol Metab. 2004 Dec;89(12):5908-9. doi: 10.1210/jc.2004-1981.
8
[The assessment of urinary glycosaminoglycans (GAG) excretion during therapy of patients with progressive Graves' ophthalmopathy].[在进展性格雷夫斯眼病患者治疗期间对尿糖胺聚糖（GAG）排泄的评估]
Pol Arch Med Wewn. 2001 Feb;105(2):139-44.
9
Orbital scintigraphy with [111In-diethylenetriamine pentaacetic acid-D-phe1]-octreotide predicts the clinical response to corticosteroid therapy in patients with Graves' ophthalmopathy.使用[111铟-二乙烯三胺五乙酸-D-苯丙氨酸1]-奥曲肽进行眼眶闪烁扫描可预测格雷夫斯眼病患者对皮质类固醇治疗的临床反应。
J Clin Endocrinol Metab. 1998 Nov;83(11):3790-4. doi: 10.1210/jcem.83.11.5274.
10
[111In-DTPA-D-Phe1] octreotide scintigraphy in thyroidal and orbital Graves' disease: a parameter for disease activity?[111铟-二乙三胺五乙酸-D-苯丙氨酸1]奥曲肽闪烁扫描术在甲状腺和眼眶格雷夫斯病中的应用：疾病活动的一个参数？
J Clin Endocrinol Metab. 1994 Dec;79(6):1845-51. doi: 10.1210/jcem.79.6.7989493.
引用本文的文献
1
Somatostatin Analogs in Clinical Practice: a Review.生长抑素类似物在临床实践中的应用：综述。
Int J Mol Sci. 2020 Feb 29;21(5):1682. doi: 10.3390/ijms21051682.
2
Lanreotide treatment in a patient with interferon-associated Graves' ophthalmopathy.兰瑞肽治疗一名干扰素相关性格雷夫斯眼病患者。
Graefes Arch Clin Exp Ophthalmol. 2005 Mar;243(3):269-72. doi: 10.1007/s00417-004-1012-x. Epub 2004 Sep 28.
3
An update on diagnostic methods in the investigation of diseases of the thyroid.甲状腺疾病诊断方法的最新进展
Eur J Nucl Med. 1996 May;23(5):587-94. doi: 10.1007/BF00833398.
本文引用的文献
1
Somatomedin C in pathogenesis of malignant exophthalmos of endocrine origin.生长调节素C在内分泌源性恶性突眼症发病机制中的作用
Lancet. 1986 Jan 25;1(8474):218-9. doi: 10.1016/s0140-6736(86)90698-7.
2
Purification of a glycosaminoglycan-stimulatory lymphokine from supernatants of in vitro-activated human mononuclear cells.从体外活化的人单核细胞上清液中纯化一种糖胺聚糖刺激淋巴细胞因子。
Clin Immunol Immunopathol. 1989 Jan;50(1 Pt 1):122-31. doi: 10.1016/0090-1229(89)90227-4.
3
Short-term somatostatin infusion affects T lymphocyte responsiveness in humans.
Immunopharmacology. 1989 Jan-Feb;17(1):45-9. doi: 10.1016/0162-3109(89)90007-6.
4
Urinary glycosaminoglycans in Graves' ophthalmopathy.格雷夫斯眼病中的尿糖胺聚糖
Clin Endocrinol (Oxf). 1990 Jul;33(1):35-44. doi: 10.1111/j.1365-2265.1990.tb00463.x.
5
Octreotide and Graves' ophthalmopathy and pretibial myxoedema.奥曲肽与格雷夫斯眼病和胫前黏液性水肿
BMJ. 1992 Jan 18;304(6820):158. doi: 10.1136/bmj.304.6820.158.
6
Octreotide and Graves' ophthalmopathy.奥曲肽与格雷夫斯眼病。
BMJ. 1992 Feb 22;304(6825):507. doi: 10.1136/bmj.304.6825.507-a.
Zotero 插件